Targeted and immunotherapy for the management of advanced urothelial carcinoma of the bladder

RJ Cersosimo - American Journal of Health-System Pharmacy, 2024 - academic.oup.com
Disclaimer In an effort to expedite the publication of articles, AJHP is posting manuscripts
online as soon as possible after acceptance. Accepted manuscripts have been peer …
相关文章

Targeted and immunotherapy for the management of advanced urothelial carcinoma of the bladder

RJ Cersosimo - American journal of health-system pharmacy … - pubmed.ncbi.nlm.nih.gov
Disclaimer In an effort to expedite the publication of articles, AJHP is posting manuscripts
online as soon as possible after acceptance. Accepted manuscripts have been peer …

Targeted and immunotherapy for the management of advanced urothelial carcinoma of the bladder.

RJ Cersosimo - American Journal of Health-system Pharmacy …, 2024 - europepmc.org
Purpose The activity of targeted and immunotherapy for the management of advanced
bladder cancer is reviewed. Summary Platinum-based chemotherapy is standard first-line …